Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Takes Over J&J/Arrowhead Hep B Candidate For Combo Development

Oct 31 2023

• By Joseph Haas

Transfer — An Arrowhead-discovered HBV candidate is going from J&J to GSK • Source: Shutterstock

Related Content

Potential For Functional Cure Opens Up With GSK’s Hepatitis B Candidate

Jun 27 2022

J&J Bets Big On Arrowhead’s Early Promise In Hepatitis B

Oct 04 2018

GSK to work with antisense firm Isis on rare and infectious diseases

Mar 31 2010

Arrowhead Gets $120m From GSK For First-In-Class NASH RNAi Candidate

Nov 23 2021

Related Companies

GSK plc

Arrowhead Pharmaceuticals, Inc.

Johnson & Johnson

Ionis Pharmaceuticals, Inc.

Additional Topics

Deals Business Strategies Commercial Infectious Diseases BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.